Chronic inflammatory diseases of the nasal mucosa such as allergic rhinitis, rhinosinusitis, and nasal polyposis pose a significant clinical burden but can be effectively managed with topically active corticosteroids (1,2). Allergic rhinitis is a chronic inflammatory disorder of the nasal mucosa triggered by environmental allergens (1). Allergic rhinitis is highly prevalent in India, with recent large‑scale studies showing that more than half of patients presenting with nasal